Evidence map›Paper›PMID 34949762›Full record

ArticleScientific reports2021

Relationship between biodosimetric parameters and treatment volumes in three types of prostate radiotherapy.

Zsuzsa S Kocsis, Tibor Major, Csilla Pesznyák, Dalma Mihály, Gábor Stelczer, Márta Kun-Gazda, Gyöngyi Farkas, Gábor Székely, Péter Ágoston, Kliton Jorgo and 3 more

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Zsuzsa S KocsisDepartment of Radiobiology and Diagnostic Onco-Cytogenetics, Centre of Radiotherapy, National Institute of Oncology, Budapest, Hungary.
Tibor MajorDepartment of Oncology, Semmelweis University, Budapest, Hungary. major.tibor@med.semmelweis-univ.hu.
Csilla PesznyákCentre of Radiotherapy, National Institute of Oncology, Budapest, Hungary.
Dalma MihályCentre of Radiotherapy, National Institute of Oncology, Budapest, Hungary.
Gábor StelczerCentre of Radiotherapy, National Institute of Oncology, Budapest, Hungary.
Márta Kun-GazdaDepartment of Radiobiology and Diagnostic Onco-Cytogenetics, Centre of Radiotherapy, National Institute of Oncology, Budapest, Hungary.
Gyöngyi FarkasDepartment of Radiobiology and Diagnostic Onco-Cytogenetics, Centre of Radiotherapy, National Institute of Oncology, Budapest, Hungary.
Gábor SzékelyDepartment of Radiobiology and Diagnostic Onco-Cytogenetics, Centre of Radiotherapy, National Institute of Oncology, Budapest, Hungary.
Péter ÁgostonDepartment of Oncology, Semmelweis University, Budapest, Hungary.
Kliton JorgoDepartment of Oncology, Semmelweis University, Budapest, Hungary.
László GesztesiCentre of Radiotherapy, National Institute of Oncology, Budapest, Hungary.
Csaba PolgárDepartment of Oncology, Semmelweis University, Budapest, Hungary.
Zsolt JurányiDepartment of Radiobiology and Diagnostic Onco-Cytogenetics, Centre of Radiotherapy, National Institute of Oncology, Budapest, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brachytherapy (BT) and external beam radiotherapy (EBRT) apply different dose rates, overall treatment times, energies and fractionation. However, the overall impact of these variables on the biological dose of blood is neglected. As the size of the irradiated volume influences the biological effect as well, we studied chromosome aberrations (CAs) as biodosimetric parameters, and explored the relationship of isodose surface volumes (ISVs: V

Indexed as

Dose Fractionation, RadiationBrachytherapyChromosome AberrationsFollow-Up StudiesHumansLymphocytesMaleProstatic NeoplasmsRadiation DosageRadiotherapy DosageRegression AnalysisTime Factors

Identifiers

PMID34949762
PMCPMC8702546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.